Abstract:Objective This study aims to investigate the difference in safety and efficacy between two treatments for venous malformations (VMs), electrochemotherapy combined with polidocanol foam (ECP) and bleomycin polidocanol foam (BPF), providing alternative therapies for VMs. Methods We conducted a retrospective review of 152 patients with venous malformations treated with ECP and BPF. Pre- and post-treatment MRI were collected, and clinical follow-up assessments were performed. Imaging results were used to calculate lesion volume changes. Clinical outcomes included changes in pain and improvements in perceived swelling. Patients were followed up at 1 week and 6 months after surgery. All emerging complications were documented in detail. Results Of the 152 patients, 87 (57.2%) received BPF treatment, 65 (42.8%) received ECP treatment. The most common location of venous malformations was the lower extremities (92/152[60.2%]), and the most common symptom was pain (108/152[71.1%]).Forty-three patients had previously undergone therapy in the BPF group (43/87[49.4%]), while 30 patients had received prior treatment in the ECP group (30/65[46.2%]). The study found that the percentage of lesion volume reduction in the BPF group was not significantly different from that in the ECP group (75.00±17.85% vs 74.69±8.48%, P = 0.899). ECP was more effective when the initial lesion volume was greater than 30 mL (67.66±12.34% vs 73.47±8.00%, P = 0.048). Patients treated with BPF had significantly less posttreatment pain than those treated with ECP, in different baseline lesion size. In the overall sample, pain relief was significantly higher in the BPF group than in the ECP group (4.21 ± 1.19 vs 3.57 ± 0.76, P = 0.002). However, there was no difference in pain relief between the two groups for the treatment of initially large venous malformations (4.20 ± 0.94 vs 3.70 ± 0.87, P = 0.113). The ECP group was significantly more likely to develop hyperpigmentation (5/87 [5.75%] vs 11/65 [16.92%], P = 0.026) and swelling (9/87 [10.34%] vs 16/65 [24.62%], P = 0.019) 1 week after surgery than the BPF group. Conclusion Our study demonstrates that both BPF and ECP are effective treatments for VMs, with BPF being a safer option. ECP, is a better choice for patients with the initial lesion volume greater than 30 mL, but it is more likely to lead to early swelling and hyperpigmentation.

Comparison of the Clinical Efficacy of Polycinnamic Foam Hardener and Absolute Ethanol in Treatment of Maxillofacial Venous Malformation

Clinical Study of Sclerotherapy of Maxillofacial Venous Malformation Using Absolute Ethanol and Pingyangmycin

Comparison Between Absolute Ethanol and Bleomycin for the Treatment of Venous Malformation in Children.

Applicaltional Study of Absolute Ethanol Injection and Pingyangmycin Instrallation with Dynamic Intranidus Infusion to Treat Venous Malformation in Maxillofacial Region

Comparative Study of Sclerotherapy of Venous Malformation in Children Using Absolute Ethanol and Pingyangmycin

Comparison of polidocanol foam versus bleomycin polidocanol foam for treatment of venous malformations

The role of intraleisonal pingyangmycin in the treatment of maxilla and facial venous malformation

Comparison of bleomycin polidocanol foam versus electrochemotherapy combined with polidocanol foam for treatment of venous malformations

Sclerotherapy of vein malformation in maxilloface with absolute ethanol under the guide of digital subtractionangiography

Treatment of head and facial arteriovenous malformation with ethanol embolization and surgical resection

Clinical Effect of Radiofrequency Ablation Combined with Digital Subtraction Angiography-Guided Percutaneous Ethanol Injection Sclerotherapy in the Management of High-Return Flow Venous Malformation

Laser irradiation after surgical exposure of the lesions combined with Pingyangnlycin injection in the management of venous malformation in oral and maxillofacial region:Report of 36 cases

Ethanol foam: a novel type of foam sclerosant for treating venous malformations

Absolute ethanol sclerotherapy for venous malformations in the face and neck.

Complications and prevention of ethanol sclerotherapy for venous malformation in head and neck

Retrospective Analysis of Neuropathy Following Sclerotherapy for Treating Venous Malformations

Effect of radiofrequency ablation combined with DSA-guided percutaneous ethanol sclerotherapy for refractory arteriovenous malformations in oral and maxillofacial region

Effect of different consistency pingyangmycin in treatment of venous malformation of oral and maxillofacial region

Copper Needle Plus Sclerotherapy in Treatment of Huge Maxillofacial Venous Malfornmtion

Sclerotherapy of venous malformation in the head and neck region with absolute ethanol under the guide of DSA

Superselective Ethanol Endovascular Therapy under Digital Subtraction Angiography for Craniofacial Arteriovenous Malformations